XTX Topco’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Sell |
17,093
-32,554
| -66% | -$568K | 0.01% | 1438 |
|
|
2025
Q1 | $625K | Buy |
49,647
+17,429
| +54% | +$219K | 0.03% | 859 |
|
|
2024
Q4 | $340K | Buy |
32,218
+14,975
| +87% | +$158K | 0.03% | 1101 |
|
|
2024
Q3 | $250K | Buy |
+17,243
| New | +$250K | 0.02% | 1306 |
|
|
2023
Q4 | – | Sell |
-10,117
| Closed | -$38.2K | – | 2105 |
|
|
2023
Q3 | $38.2K | Buy |
+10,117
| New | +$38.2K | 0.01% | 1305 |
|
|
2022
Q3 | – | Sell |
-10,001
| Closed | -$42K | – | 1362 |
|
|
2022
Q2 | $42K | Sell |
10,001
-12,136
| -55% | -$51K | 0.02% | 760 |
|
|
2022
Q1 | $78K | Buy |
22,137
+3,321
| +18% | +$11.7K | 0.03% | 546 |
|
|
2021
Q4 | $125K | Buy |
+18,816
| New | +$125K | 0.07% | 434 |
|